Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology
(2017) In Journal of Nuclear Medicine 58(4). p.623-631
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1b5bca37-5339-4a9b-9759-9eb28491a0b6
- author
- organization
- publishing date
- 2017
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Nuclear Medicine
- volume
- 58
- issue
- 4
- pages
- 623 - 631
- publisher
- Society of Nuclear Medicine
- external identifiers
-
- pmid:27765859
- scopus:85017125348
- wos:000398249600025
- ISSN
- 0161-5505
- DOI
- 10.2967/jnumed.116.174508
- language
- English
- LU publication?
- yes
- id
- 1b5bca37-5339-4a9b-9759-9eb28491a0b6
- date added to LUP
- 2017-04-03 15:01:48
- date last changed
- 2022-04-24 22:58:58
@article{1b5bca37-5339-4a9b-9759-9eb28491a0b6, author = {{Hahn, Andreas and Schain, Martin and Erlandsson, Maria and Sjölin, Petter and James, Gregory and Strandberg, Olof and Hägerström, Douglas and Lanzenberger, Rupert and Jögi, Jonas and Olsson, Tomas G and Smith, Ruben and Hansson, Oskar}}, issn = {{0161-5505}}, language = {{eng}}, number = {{4}}, pages = {{623--631}}, publisher = {{Society of Nuclear Medicine}}, series = {{Journal of Nuclear Medicine}}, title = {{Modeling strategies for quantification of in vivo 18F-AV1451 binding in patients with tau pathology}}, url = {{http://dx.doi.org/10.2967/jnumed.116.174508}}, doi = {{10.2967/jnumed.116.174508}}, volume = {{58}}, year = {{2017}}, }